The Chicago Cubs and Registration Trial Design
I used to be more certain of things. The Chicago Cubs would...
Read More
Four Steps To Assess Drug Value
Can Number Needed to Treat (NNT) and drug cost provide a concise...
Read More
The 21st Century Cures Act – Full Speed Ahead?
The 21st Century Cures Act 1 is focused on improving the discovery,...
Read More
FDAMA 114 & The 21st Century Cures Bill
The 21st Century Cures bill includes language proposing modifications to FDAMA 114....
Read More
Is Your HEOR Group Commercially Relevant?
The greatest challenge to a building a commercially relevant HEOR group is...
Read More
What Do Payers Need From Pharmaceutical Companies?
Payers Need Three Things 1 – Relevant Innovation & Evidence Relevant innovation...
Read More
Pharmaceutical Due Diligence: Payer Evaluation Criteria
Background Due diligence is a common yet critical practice in the pharmaceutical...
Read More